WHY PHILANTHROPY SHOULD FUND THE QUESTION BEFORE THE ANSWER

Some of the most important scientific questions sound compelling long before they look fundable.

That is one of the problems with early-stage research. By the time an idea has enough preliminary data, enough validation, enough institutional support, and enough evidence to look “safe,” someone has already spent years doing the work required to make it look that way. The earliest stage is often where uncertainty is highest and evidence is thinnest, but it is also where some of the most interesting questions live.

At the JKTG Foundation, I have become increasingly convinced that one of the most useful things philanthropy can do is support a question before the answer is obvious. That does not mean funding every idea that sounds provocative or lowering the standards of good science. It means recognizing that important research often begins before there is enough certainty to satisfy a traditional funding process.

Why Early-Stage Research Is So Difficult to Fund

Traditional research funding has to manage risk, and that is understandable. Public agencies are responsible for large amounts of money, and peer review is designed in part to evaluate whether a project is scientifically sound, feasible, and likely to produce useful results. The problem is that the more novel the question, the less evidence may exist to prove that the proposed approach will work.

That creates a built-in tension.

Researchers are often asked to demonstrate enough preliminary evidence to show that an idea is promising, but producing that evidence requires time, tools, experiments, models, and money. Someone has to support that first stage before the project can become competitive for larger funding.

NIH itself recognizes this gap through programs designed specifically for high-risk, high-reward or exploratory research that may not fit neatly into conventional review structures. That tells us something important: promising ideas can fall between “interesting” and “proven enough.” Philanthropy can help bridge that space.

The Question Comes Before the Evidence

Every established field of research began with someone asking a question that did not yet have a complete answer.

What causes this? Why does that happen? What are we missing? What if the explanation everyone accepts is incomplete?

Those questions may sound simple, but they are the beginning of almost everything. Science cannot generate evidence until researchers have enough support to go looking for it. That is why I do not believe early uncertainty should automatically be treated as a weakness. Sometimes the uncertainty is precisely what makes the research worth doing.

If we already knew the answer, it would not be research.

The challenge for funders is deciding which unanswered questions deserve the opportunity to be tested. That requires judgment, but it also requires a willingness to accept that not every worthwhile project will arrive with a polished roadmap and a predictable result.

Philanthropy Can Fund Curiosity Before Consensus

Private philanthropy has an advantage that larger funding systems often do not: it can move earlier and with more flexibility. A foundation can support a scientist or team because the question is compelling, the logic is sound, and the potential insight matters, even if the project does not yet come packaged with years of supporting evidence.

That flexibility becomes especially valuable in areas where the science is still forming. Early-stage and curiosity-driven research can be difficult for commercial funders because it may have no obvious near-term financial return. It can also be difficult for traditional public funding because the work may be considered too speculative or insufficiently validated.

Philanthropy does not have to make the same calculation. We do not need every project to arrive with a business case or a near-certain outcome. We need to ask whether the question is important enough to understand and whether the researchers are capable of pursuing it rigorously.

Funding Risk Is Not the Same as Funding Recklessness

There is an important distinction between being comfortable with uncertainty and being careless with money.

Funding earlier does not mean abandoning rigor. The science still has to make sense. The researchers still need the expertise to do the work. The question still needs to matter, and the proposed approach still has to be thoughtful.

What changes is the tolerance for uncertainty.

A funder can acknowledge that the hypothesis may be wrong while still believing the experiment is worth conducting. In fact, if every project you support has an obvious outcome before it begins, you may not be taking much scientific risk at all.

The goal is not to fund bad science. The goal is to avoid rejecting good science simply because it is early.

Preliminary Data Has to Come From Somewhere

One of the ironies of research funding is that investigators are frequently asked to show preliminary evidence before they receive meaningful support. Yet producing that preliminary evidence costs money. Someone has to fund the first experiment, the first model, the first dataset, or the first attempt to determine whether the idea has merit.

That is one place where philanthropic capital can have an outsized effect. A relatively modest early investment may allow a researcher to produce the evidence needed to pursue a much larger grant later. In that sense, philanthropy is not only funding a project. It may be helping that project become fundable by others.

That leverage matters. The best philanthropic investment is not necessarily the one that carries the work all the way to the finish line. Sometimes the highest-value role is helping a promising question survive long enough to reach the next stage.

Being Wrong Can Still Move Science Forward

Research funding also requires a different definition of success than many other kinds of investment. A project can be valuable even when the original hypothesis turns out to be wrong.

Finding out what does not work narrows the field. It eliminates assumptions, redirects effort, and may prevent other researchers from spending years pursuing the same dead end. Science moves forward when evidence replaces uncertainty, even when the evidence does not support the original idea.

That is why I worry about funding systems that reward certainty too heavily. If researchers feel they have to make every proposal look nearly guaranteed to succeed, we create an incentive to pursue safer questions rather than harder ones.

Philanthropy has the ability to tolerate a little more uncertainty because the value of the work may be in what we learn, not simply whether the original hypothesis survives.

Why Basic Science Still Matters

There is understandable pressure to fund research that appears close to a treatment, diagnostic, or immediate patient benefit. Those projects matter enormously, but the work closest to the patient depends on knowledge created much earlier.

Before we can design a better treatment, we often have to understand how the disease behaves. Before we can interrupt a biological process, we have to understand that process. Before we know which target matters, we need to know what the system is actually doing.

That is basic science. It can be slow, messy, difficult to explain, and far removed from an immediate clinical result. It is also essential.

At JKTG, that is one reason we have been willing to support work that asks foundational questions. The path from a basic biological question to a future treatment may not be obvious at the beginning, but without that foundational understanding, later-stage progress has nothing solid to stand on.

Philanthropy Should Help Good Questions Survive

I do not believe philanthropy should try to replace government research funding. The scale is completely different, and public funding remains essential to scientific progress.

The opportunity for philanthropy is to play a different role. We can move earlier, support unconventional collaborations, give researchers room to test an idea before the answer is obvious, and help generate the evidence that allows the next stage of funding to happen.

In other words, philanthropy can help good questions survive long enough to become good science.

That is a role worth taking seriously, because the next important discovery may not begin with a polished answer. It may begin with someone asking a question nobody is quite ready to fund yet.